Search - tctmd.com

Displaying 101 - 120 of 5357

Sort: Relevancy | Date

Presentation TCT 2025

TCT 319: Short -Term Clinical Effect of Cerebral Embolic Protection Device Following Transcatheter Aortic-Valve Replacement in Korea Population: The Sentinel Registry (Sentinel)

Presenter: Han Su Park

October 26, 2025

Presentation TCT 2025

TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience

Presenter: P. Michael Grossman

October 26, 2025

Presentation TCT 2025

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Hasan Ilyas

October 26, 2025

Presentation TCT 2025

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mostafa Ali

October 26, 2025

Presentation TCT 2025

TCT 1455: When MAC Attacks: Stroke-Driven Discovery and Percutaneous Removal of a Mobile Mitral Annular Mass via Transseptal AngioVac With Cerebral Protection

Presenter: Huseyin Emre Arman

October 26, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

Presentation TCT 2025

TCT 753: Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes

Presenter: Rakendu Jayasree Rajendran

October 25, 2025

Presentation TCT 2025

TCT 822: Prognostic Implications of Forward Stroke Volume Index After Mitral Transcatheter Edge-to-Edge Repair in Patients With Ventricular Functional Mitral Regurgitation

Presenter: Masafumi Yoshikawa

October 25, 2025

Presentation TCT 2025

ARS 1: The Art of Disruptive Innovation: Process or the Stroke of Genius

Presenter: Andrew D. Cleeland

October 25, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Daily News

Alterations in Alcohol Use, Even at Low Levels, Impact BP

Todd Neale

October 24, 2025

News Daily News

A Little Exercise, No Matter When It’s Done, Benefits Older Women

Michael O'Riordan

October 24, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Caitlin E. Cox

October 21, 2025

News Conference News EACTS 2025

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

Yael L. Maxwell

October 16, 2025

News Conference News EACTS 2025

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

Yael L. Maxwell

October 13, 2025

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Daily News

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

Caitlin E. Cox

October 08, 2025

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

L.A. McKeown

October 03, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

Advertisement

TCT 319: Short -Term Clinical Effect of Cerebral Embolic Protection Device Following Transcatheter Aortic-Valve Replacement in Korea Population: The Sentinel Registry (Sentinel)

TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

TCT 1455: When MAC Attacks: Stroke-Driven Discovery and Percutaneous Removal of a Mobile Mitral Annular Mass via Transseptal AngioVac With Cerebral Protection

October 2025 Dispatch for the CV Team

TCT 753: Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes

TCT 822: Prognostic Implications of Forward Stroke Volume Index After Mitral Transcatheter Edge-to-Edge Repair in Patients With Ventricular Functional Mitral Regurgitation

ARS 1: The Art of Disruptive Innovation: Process or the Stroke of Genius

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Alterations in Alcohol Use, Even at Low Levels, Impact BP

A Little Exercise, No Matter When It’s Done, Benefits Older Women

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

Evolocumab Wins for Primary Prevention in VESALIUS-CV

Risk Factors Present in Nearly All Patients Who Develop CVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content